Your browser doesn't support javascript.
loading
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters.
Abdelnabi, Rana; Foo, Caroline S; Zhang, Xin; Lemmens, Viktor; Maes, Piet; Slechten, Bram; Raymenants, Joren; André, Emmanuel; Weynand, Birgit; Dallmeier, Kai; Neyts, Johan.
Afiliación
  • Abdelnabi R; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000, Leuven, Belgium.
  • Foo CS; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000, Leuven, Belgium.
  • Zhang X; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000, Leuven, Belgium.
  • Lemmens V; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000, Leuven, Belgium; Molecular Vaccinology and Vaccine Discovery, Leuven, Belgium.
  • Maes P; Laboratory of Clinical and Epidemiological Virology, Rega Institute, KU Leuven, Department of Microbiology, Immunology and Transplantation, 3000, Leuven, Belgium; Zoonotic Infectious Diseases Unit, Leuven, Belgium.
  • Slechten B; Department of Laboratory Medicine, UZ Leuven Hospital, 3000, Leuven, Belgium.
  • Raymenants J; Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000, Leuven, Belgium.
  • André E; Department of Laboratory Medicine, UZ Leuven Hospital, 3000, Leuven, Belgium; Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000, Leuven, Belgium.
  • Weynand B; KU Leuven Department of Imaging and Pathology, Translational Cell and Tissue Research, Division of Translational Cell and Tissue Research, B-3000, Leuven, Belgium.
  • Dallmeier K; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000, Leuven, Belgium; Molecular Vaccinology and Vaccine Discovery, Leuven, Belgium; Global Virus Network, GVN, Leuven, Belgium.
  • Neyts J; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000, Leuven, Belgium; Molecular Vaccinology and Vaccine Discovery, Leuven, Belgium; Global Virus Network, GVN, Leuven, Belgium. Electronic address: j
Antiviral Res ; 198: 105253, 2022 02.
Article en En | MEDLINE | ID: mdl-35066015

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Modelos Animales de Enfermedad / SARS-CoV-2 / COVID-19 Límite: Animals / Humans Idioma: En Revista: Antiviral Res Año: 2022 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Modelos Animales de Enfermedad / SARS-CoV-2 / COVID-19 Límite: Animals / Humans Idioma: En Revista: Antiviral Res Año: 2022 Tipo del documento: Article País de afiliación: Bélgica